Moreover, a recent study showed that miR-26a was downregulated in DN and it may target connective tissue growth factor (CTGF) to inhibit TGF-β-induced extracellular matrix protein expression in podocytes [66]. This evidence concerns the gene TGFB1 and liver dysplastic nodule.